19-11166556-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001136191.3(KANK2):c.*2C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 1,612,072 control chromosomes in the GnomAD database, including 178,432 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.51 ( 21422 hom., cov: 33)
Exomes 𝑓: 0.46 ( 157010 hom. )
Consequence
KANK2
NM_001136191.3 3_prime_UTR
NM_001136191.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.65
Genes affected
KANK2 (HGNC:29300): (KN motif and ankyrin repeat domains 2) This gene encodes a member of the KN motif and ankyrin repeat domains (KANK) family of proteins, which play a role in cytoskeletal formation by regulating actin polymerization. The encoded protein functions in the sequestration of steroid receptor coactivators and possibly other proteins. Mutations in this gene are associated with impaired kidney podocyte function and nephrotic syndrome, and keratoderma and woolly hair. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-11166556-G-A is Benign according to our data. Variant chr19-11166556-G-A is described in ClinVar as [Benign]. Clinvar id is 1295464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.7 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KANK2 | NM_001136191.3 | c.*2C>T | 3_prime_UTR_variant | 13/13 | ENST00000586659.6 | NP_001129663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KANK2 | ENST00000586659.6 | c.*2C>T | 3_prime_UTR_variant | 13/13 | 1 | NM_001136191.3 | ENSP00000465650.1 | |||
KANK2 | ENST00000588787.5 | c.*2C>T | 3_prime_UTR_variant | 5/5 | 5 | ENSP00000464896.1 | ||||
KANK2 | ENST00000587317.1 | n.425C>T | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
KANK2 | ENST00000589359.5 | c.*2C>T | downstream_gene_variant | 5 | ENSP00000468002.1 |
Frequencies
GnomAD3 genomes AF: 0.514 AC: 78159AN: 151996Hom.: 21376 Cov.: 33
GnomAD3 genomes
AF:
AC:
78159
AN:
151996
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.435 AC: 108583AN: 249626Hom.: 24987 AF XY: 0.436 AC XY: 58834AN XY: 135072
GnomAD3 exomes
AF:
AC:
108583
AN:
249626
Hom.:
AF XY:
AC XY:
58834
AN XY:
135072
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.459 AC: 670370AN: 1459958Hom.: 157010 Cov.: 34 AF XY: 0.457 AC XY: 331773AN XY: 726374
GnomAD4 exome
AF:
AC:
670370
AN:
1459958
Hom.:
Cov.:
34
AF XY:
AC XY:
331773
AN XY:
726374
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.514 AC: 78248AN: 152114Hom.: 21422 Cov.: 33 AF XY: 0.508 AC XY: 37766AN XY: 74370
GnomAD4 genome
AF:
AC:
78248
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
37766
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1309
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at